This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In addition, exposure of the fetus or neonate to either persistent arrhythmias or antiarrhythmic medications may have yet-to-be-determined long-term developmental consequences. Treatment options are limited in the fetus and neonate because of limited vascular access, patient size, and the significant risk/benefit ratio of any intervention.
Surgical modifications and hemodynamic changes increase the susceptibility to arrhythmias, impacting morbidity and mortality rates, with arrhythmias being the leading cause of hospitalizations and sudden deaths. Macroreentrant atrial tachycardias, particularly cavotricuspid isthmus-dependent flutter, are frequently reported.
Arrhythmias, and in particular atrial fibrillation (AF), are one of the greatest healthcare challenges of our time. Arrhythmia prediction models have long relied on conventional risk factors such as age, diabetes, hypertension, and history of myocardial infarction and heart failure.
Recent studies have highlighted the critical role of calcium/calmodulin-dependent protein kinase II (CaMKII) overactivation in the pathogenesis of various cardiac arrhythmias.
The increased risk of arrhythmias and sudden cardiac death (SCD) caused by drug-induced QT prolongation has been a prominent safety pharmacology concern for the last 30 years.
Loss-of-function SCN5A channelopathies, such as Brugada syndrome (BrS), are cardiac disorders marked by diminished sodium current (INa), conduction slowing, and lethal arrhythmias.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. The acquisition of Laminar, Inc.
Using electroanatomic mapping (EAM) we discovered cardiac activation delay, which creates the milieu for functional reentrant ventricular arrhythmias. We thus developed a knock-in TS1 porcine model that reproduces all cardinal features of the human disease and as such represents a unique platform for drug testing.
Supraventricular tachycardias are the most common arrhythmias that occur during pregnancy. Pharmacologic therapy is often preferred in pregnant patients. When pharmacologic therapy fails, fluoroless catheter ablation utilizing electroanatomic mapping systems and intracardiac echocardiography (ICE) may be considered.
Introduction The incidence of arrhythmia in heart failure with non-reduced ejection fraction (HFnon-rEF) in patients who have a history of hospitalisation is unclear. Methods and analysis This is a multicentre single arm study to evaluate the usefulness of ILR for detecting arrhythmia.
Abstract Introduction Arrhythmia occurs as a common heart vascular disease. Functional food is a rich source of natural compounds with significant pharmacological, The aim of this paper is to explore its effect on arrhythmia.
In some cases the ischemia can be seen "through" the flutter waves, whereas in other cases the arrhythmia must be terminated before the ischemia can be clearly distinguished. We discussed several pharmacologic and electrical options. 2) Tachycardia to this degree can cause ST segment changes in several ways.
Congenital Long QT Syndrome (LQTS) can result in fatal cardiac arrhythmias. The main pharmacological treatment includes beta-blockers; however, while effective at reducing cardiac events, beta-blockers do not treat underlying mechanisms of the disease, and patients occasionally experience breakthrough cardiac events or side effects.
Congenital Long QT Syndrome (LQTS) can result in fatal cardiac arrhythmias. The main pharmacological treatment includes beta-blockers; however, while effective at reducing cardiac events, beta-blockers do not treat underlying mechanisms of the disease, and patients occasionally experience breakthrough cardiac events or side effects.
Concerns regarding the risk of cardiac arrhythmia and death have been raised, yet the burden of HCQ and CQ-related cardiac toxicities remains unclear. Concerns regarding the risk of cardiac arrhythmia and death have been raised, yet the burden of HCQ and CQ-related cardiac toxicities remains unclear.
Intravenous (IV) digoxin loading dose recommendations for rate control of atrial arrhythmias in critically ill patients are not well studied. Intravenous (IV) digoxin loading dose recommendations for rate control of atrial arrhythmias in critically ill patients are not well studied. ng/mL is recommended. ng/mL is recommended.
ABSTRACTAtrial fibrillation (AF) is the most common cardiac arrhythmia. However, studies on how obesity affects pharmacologic or interventional AF treatments are limited. Journal of the American Heart Association, Ahead of Print. AF increases the risk of stroke, heart failure, dementia, and hospitalization.
Atrial fibrillation (AF), the most prevalent cardiac arrhythmia, is closely linked to metabolic dysfunctions, including obesity, diabetes, and dyslipidemia. These lead to pathological changes in myocardial metabolism and mitochondrial energy metabolism, thereby aggravating AF's incidence and severity.
T-wave alternans and the susceptibility to ventricular arrhythmias. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Both ST segment and T wave alternans have been known to precede malignant ventricular arrhythmias. Pacing Clin Electrophysiol.
The key risk factor for cardioembolic stroke is atrial fibrillation or flutter, and oral anticoagulation (OAC) is recommended in all but the lowest-risk patients with evidence of these arrhythmias. Overall, comprehensive assessment and pharmacological modification of risk factors are central to stroke prevention.
Abstract Introduction Premature ventricular complexes (PVCs) are the most common ventricular arrhythmia that are encountered in the clinical practice. Both antiarrhythmic drugs (AADs) and catheter ablation (CA) are recognized treatment modalities for any cardiac arrhythmias.
Cardiac fibrosis is a pathological hallmark of almost all forms of heart disease, characterized by excessive deposition of extracellular matrix (ECM) proteins by activated fibroblasts, leading to cardiomyocyte hypertrophy, arrhythmias, and heart failure.
What is unusual about this arrhythmia? Doing so suggests that the R-R interval of this exceedingly rapid arrhythmia is just a tiny amount over 1 large box — which corresponds to a ventricular rate just under 300/minute ( ie, between 290-300/minute ). How would YOU interpret the ECG in Figure-1 ?
Pharmacological Interventions : Use of antihypertensive medications, lipid-lowering agents, and antidiabetic drugs. Arrhythmias : A leadless pacemaker-defibrillator system provides antitachycardia pacing for ventricular tachycardia in patients with subcutaneous ICDs.
Amphetamine derivatives are used worldwide legally or illegally and intoxications may be accompanied by cardiac arrhythmias. Amphetamine derivatives are used worldwide legally or illegally and intoxications may be accompanied by cardiac arrhythmias.
Since the patient was stable and tolerating the arrhythmia it was decided to treat with IV Amiodarone for medical conversion. Hence, the IV Amiodarone was once one of the 2nd-line choices for acute pharmacologic cardioversion in such patients without hemodynamic instability. Smith : What do you think?
IV administration of potassium is indicated when arrhythmias are present or hypokalemia is severe (potassium level of less than 2.5 malignant ventricular arrhythmias are present), rapid replacement of potassium is required. Arrhythmias, changes in cardiac conduction intervals, and other complications did not occur.
Atrial fibrillation (AF) is the most common arrhythmia in humans. It affects 5% of the population over the age of 65 years and is projected to rise as the population ages. Experimental data from animal models of AF shows that AF is associated with progressive structural and electrical remodeling of the atria.
If the rhythm converts and then reverts to tachycardia with either adenosine or electricity, Neither one of those modalities should be attempted until some longer acting pharmacological solution is given. WPW does not always have delta waves on the baseline ECG. This is called "Concealed conduction".
myocardial infarction), arrhythmias, valvular pathology, shunts, or outflow obstructions. Fundamentally, cardiogenic shock is an issue of decreased cardiac output. This may be secondary to multiple factors, including decreased cardiac contractility (ie. As with other cases of shock, initial fluid resuscitation may be considered.
Both ST segment and T wave alternans have been known to precede malignant ventricular arrhythmias. This may result from fluctuations in heart rate or in nervous system activity or from pharmacologic treatment. In patients with a long QT — T wave alternans may forebode impending Torsades de Pointes.
BackgroundMyocardial fibrosis (MF) is a prevalent pathological condition associated with various heart diseases, such as heart failure and arrhythmias, which disrupt electrical signals and reduce pumping efficiency. This research explored the therapeutic effects and potential mechanisms of Ligustrum vicaryi L.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
78 
Let's personalize your content